Allogeneic haematopoietic stem cell transplantation resets T‐ and B‐cell compartments in sickle cell disease patients. Issue 4 (23rd April 2022)
- Record Type:
- Journal Article
- Title:
- Allogeneic haematopoietic stem cell transplantation resets T‐ and B‐cell compartments in sickle cell disease patients. Issue 4 (23rd April 2022)
- Main Title:
- Allogeneic haematopoietic stem cell transplantation resets T‐ and B‐cell compartments in sickle cell disease patients
- Authors:
- Jarduli‐Maciel, Luciana Ribeiro
de Azevedo, Júlia Teixeira Cottas
Clave, Emmanuel
Costa, Thalita Cristina de Mello
Arruda, Lucas Coelho Marlière
Fournier, Isabelle
Palma, Patrícia Vianna Bonini
Lima, Keli Cristina
Elias, Juliana Bernardes
Stracieri, Ana Beatriz PL
Pieroni, Fabiano
Cunha, Renato
Darrigo‐Júnior, Luiz Guilherme
Grecco, Carlos Eduardo Settani
Covas, Dimas Tadeu
Silva‐Pinto, Ana Cristina
De Santis, Gil Cunha
Simões, Belinda Pinto
Oliveira, Maria Carolina
Toubert, Antoine
Malmegrim, Kelen Cristina Ribeiro - Abstract:
- Abstract: Objectives: Allogeneic haematopoietic stem cell transplantation (allo‐HSCT) is the only currently available curative treatment for sickle cell disease (SCD). Here, we comprehensively evaluated the reconstitution of T‐ and B‐cell compartments in 29 SCD patients treated with allo‐HSCT and how it correlated with the development of acute graft‐versus‐host disease (aGvHD). Methods: T‐cell neogenesis was assessed by quantification of signal‐joint and β‐chain TCR excision circles. B‐cell neogenesis was evaluated by quantification of signal‐joint and coding‐joint K‐chain recombination excision circles. T‐ and B‐cell peripheral subset numbers were assessed by flow cytometry. Results: Before allo‐HSCT (baseline), T‐cell neogenesis was normal in SCD patients compared with age‐, gender‐ and ethnicity‐matched healthy controls. Following allo‐HSCT, T‐cell neogenesis declined but was fully restored to healthy control levels at one year post‐transplantation. Peripheral T‐cell subset counts were fully restored only at 24 months post‐transplantation. Occurrence of acute graft‐versus‐host disease (aGvHD) transiently affected T‐ and B‐cell neogenesis and overall reconstitution of T‐ and B‐cell peripheral subsets. B‐cell neogenesis was significantly higher in SCD patients at baseline than in healthy controls, remaining high throughout the follow‐up after allo‐HSCT. Notably, after transplantation SCD patients showed increased frequencies of IL‐10‐producing B‐regulatory cells and IgM +Abstract: Objectives: Allogeneic haematopoietic stem cell transplantation (allo‐HSCT) is the only currently available curative treatment for sickle cell disease (SCD). Here, we comprehensively evaluated the reconstitution of T‐ and B‐cell compartments in 29 SCD patients treated with allo‐HSCT and how it correlated with the development of acute graft‐versus‐host disease (aGvHD). Methods: T‐cell neogenesis was assessed by quantification of signal‐joint and β‐chain TCR excision circles. B‐cell neogenesis was evaluated by quantification of signal‐joint and coding‐joint K‐chain recombination excision circles. T‐ and B‐cell peripheral subset numbers were assessed by flow cytometry. Results: Before allo‐HSCT (baseline), T‐cell neogenesis was normal in SCD patients compared with age‐, gender‐ and ethnicity‐matched healthy controls. Following allo‐HSCT, T‐cell neogenesis declined but was fully restored to healthy control levels at one year post‐transplantation. Peripheral T‐cell subset counts were fully restored only at 24 months post‐transplantation. Occurrence of acute graft‐versus‐host disease (aGvHD) transiently affected T‐ and B‐cell neogenesis and overall reconstitution of T‐ and B‐cell peripheral subsets. B‐cell neogenesis was significantly higher in SCD patients at baseline than in healthy controls, remaining high throughout the follow‐up after allo‐HSCT. Notably, after transplantation SCD patients showed increased frequencies of IL‐10‐producing B‐regulatory cells and IgM + memory B‐cell subsets compared with baseline levels and with healthy controls. Conclusion: Our findings revealed that the T‐ and B‐cell compartments were normally reconstituted in SCD patients after allo‐HSCT. In addition, the increase of IL‐10‐producing B‐regulatory cells may contribute to improve immune regulation and homeostasis after transplantation. Abstract : In this study, we found that allogeneic hematopoietic stem cell transplantation resets the T‐ and B‐cell compartments in sickle cell disease patients. In addition, the increase of IL‐10‐producing B‐regulatory cells after transplantation may contribute to improve immune regulation and homeostasis. … (more)
- Is Part Of:
- Clinical & translational immunology. Volume 11:Issue 4(2022)
- Journal:
- Clinical & translational immunology
- Issue:
- Volume 11:Issue 4(2022)
- Issue Display:
- Volume 11, Issue 4 (2022)
- Year:
- 2022
- Volume:
- 11
- Issue:
- 4
- Issue Sort Value:
- 2022-0011-0004-0000
- Page Start:
- n/a
- Page End:
- n/a
- Publication Date:
- 2022-04-23
- Subjects:
- allogeneic haematopoietic stem cell transplantation -- B‐cell neogenesis -- peripheral homeostasis -- sickle cell disease -- T‐cell neogenesis
Immunologic diseases -- Periodicals
Immunology -- Periodicals
Clinical medicine -- Periodicals
Immune System Diseases -- therapy
Immunotherapy
Immunologic Factors -- therapeutic use
Translational Medical Research
Molecular Targeted Therapy
Clinical medicine
Immunologic diseases
Immunology
Periodicals
Periodicals
Fulltext
Internet Resources
Periodicals
616.079 - Journal URLs:
- http://www.nature.com/cti/index.html ↗
http://www.ncbi.nlm.nih.gov/pmc/journals/2610/ ↗
http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2050-0068 ↗
http://www.nature.com/ ↗
http://www.nature.com/cti/index.html ↗ - DOI:
- 10.1002/cti2.1389 ↗
- Languages:
- English
- ISSNs:
- 2050-0068
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 21364.xml